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STUDY PROTOCOL Open Access
Effectiveness of a transdiagnostic
individually tailored Internet-based and
mobile-supported intervention for the
indicated prevention of depression and
anxiety (ICare Prevent) in Dutch college
students: study protocol for a randomised
controlled trial
Felix Bolinski1,2* , Annet Kleiboer1,2, Eirini Karyotaki1,2, Judith E. Bosmans3, Anna-Carlotta Zarski4, Kiona K. Weisel4,
David D. Ebert4, Corinna Jacobi5, Pim Cuijpers1,2 and Heleen Riper1,2
Abstract
Background: Depression and anxiety are common and co-morbid disorders that affect a significant proportion of
students. Innovative prevention strategies targeting both conditions are needed to reduce their health burden and
costs. ICare Prevent is such an innovative strategy and contains a transdiagnostic individually tailored Internet-based
and mobile-supported intervention. It addresses common risk factors of depression and anxiety as part of a large
EU-funded multi-country project* (ICare). Little is known about the clinical and cost-effectiveness of this type of
intervention compared to care as usual (CAU) for college students. We hypothesize that ICare Prevent will be more
(cost-)effective than CAU in the reduction of symptoms of depression and anxiety.
Methods: A three-arm, parallel, randomized controlled superiority trial will be conducted comparing a guided and
an unguided version of ICare Prevent with a control group receiving CAU. The trial will be open-label but outcome
assessors will be blinded. A total of 252 college students (age ≥ 16 years) with subclinical symptoms of depression
defined as a score ≥ 16 on the Center for Epidemiological Studies Depression Scale (CES-D), and/or anxiety, defined
as a score ≥ 5 on the Generalized Anxiety Disorder scale (GAD-7), will be included. Those meeting diagnostic criteria
for a depressive or anxiety disorder will be excluded. The primary outcome is change in disorder specific symptom
severity from baseline to post-intervention. Secondary endpoints include self-reported depression and anxiety
symptoms as well as time to onset of a mood or anxiety disorder until 12-month follow-up. Societal costs and
quality of life will be assessed to estimate the intervention’s cost-effectiveness compared to CAU.
(Continued on next page)
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Discussion: Transdiagnostic individually tailored Internet-based prevention could be a (cost-)effective approach to
tackle the disease burden of depression and anxiety among college students.
Trial registration: Dutch trial register, NTR 6562. Registered on 6 July 2017.
Keywords: Depression, Anxiety, Prevention, Internet-based intervention, Cognitive behavioral therapy, Students,
Randomized controlled trial,
Background
Depression and anxiety are highly prevalent and debilitating
conditions that are associated with considerable economic
costs [1–5]. Both disorders have their peak onset in early
adulthood, including college years [6, 7]. College students
often experience a variety of stressors (e.g. gaining personal
and financial independence), which have the potential to
trigger or exacerbate symptoms of mental health conditions
[8, 9]. Correspondingly, > 20% of all college students suffer
from a mental condition, ranking anxiety and depression on
top [10–12].
Depression and anxiety during college years have several
negative consequences for students and society. For ex-
ample, a younger age of onset of depression and anxiety
has been linked to a more severe and chronic disease tra-
jectory, as well as a higher risk for developing co-morbid
psychiatric disorders in adulthood [8, 13, 14]. Moreover, it
is clear that anxiety and depression negatively influence
academic performance and increase the possibility of col-
lege dropout [15, 16]. On a societal level, college students’
untreated depression and anxiety may have significant im-
plications for human capital, specifically when their future
employment and income is considered [17, 18].
Preventing the development of these mental health
conditions in college students is thus of great importance.
Hence, recommendations have been made to implement
university-based early detection and prevention programs
[19]. These can be distinguished as universal (targeting a
population as a whole), selective (providing an intervention
to individuals with a specific risk profile), and indicated (tar-
geted to those who already experience elevated symptoms
below clinical thresholds) ([20]; p. 20–21). According to
previous research, face-to-face college-based universal
prevention programs show small to moderate effects in
reducing depression or anxiety severity [21]. Yet, data on
selective and indicated university-based prevention ap-
proaches are scarce, though their application may be par-
ticularly effective because they are targeted at those who
need help the most ([22], p. 499). Specifically, indicated pre-
vention has been described as the preferred approach based
on its potential for detecting and efficiently helping those
who have a high risk of developing depression [23].
Internet-based interventions have the potential to fill
the gap between the limited university healthcare facilities
and the treatment demand [24–26]. In contrast to face-to-
face psychotherapy, this approach depends less on therap-
ist availability, offers low-threshold access, and the possi-
bility to use the intervention at any time and place.
Moreover, it provides a high degree of anonymity and thus
tackles the issue of stigma associated with mental health
problems, which negatively affects college students’ help-
seeking behavior [17, 18]. In clinical populations, the
effectiveness of such Internet-based interventions for anx-
iety and depression has already been established [27, 28],
especially if they are provided with some form of thera-
peutic guidance [29]. With regard to prevention of depres-
sion or anxiety, the evidence regarding the effectiveness of
Internet-based interventions is inconclusive. Recent trials
comparing indicated prevention programs to controls
have shown mixed effects, varying from no differences be-
tween the conditions to moderate effects on reduction of
incidence rates in favor of the Internet-based preventive
program [24–26, 30, 31].
However, to the best of our knowledge, no randomized
controlled trial on the effects of online indicated prevention
of depression and anxiety has been conducted in a pure col-
lege student population. Moreover, past research has largely
focused on disorder-specific interventions for the online
treatment and prevention of these conditions. Adding trans-
diagnostic components may address their co-morbidity bet-
ter, as well as common underlying factors, such as general
negative affect and disturbed information processing [32].
Recent meta-analytic evidence on Internet-based interven-
tions has shown that transdiagnostic approaches have no
differential effect for anxiety when compared to disorder
specific approaches, but they do perform significantly better
in the reduction of depressive symptoms [33].
Finally, the cost-effectiveness of Internet-based indicated
prevention programs and the added value of human sup-
port remain unclear. Though some studies suggest that
Internet-based treatment has the potential to be cost-
effective [24–26, 34–36], the evidence for prevention is
limited. The economic evaluation of the Internet-based pre-
vention program developed by Buntrock et al. [37] shows
that such an indicated prevention of depression through the
Internet can have a large likelihood to be cost-effective
when compared to enhanced usual care. Moreover,
although asynchronous support (e.g. by email) has been
shown to have beneficial effects on outcomes and retention
[38–40], information on the cost-effectiveness of such an
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investment (e.g. time and costs of eCoach) as com-
pared to no human support for Internet-based pre-
vention of anxiety and depression among students is
lacking. Examining further the cost effectiveness of
guided and unguided Internet-based indicated preven-
tion in a student population is essential.
Trial objectives
We designed a randomized controlled trial to evaluate
the (cost-)effectiveness of a transdiagnostic individually
tailored online intervention compared with care as usual
(CAU) in reducing symptoms and preventing the onset
of a full episode of depression and anxiety in college stu-
dents. We hypothesize that participants in the two active
intervention groups will experience larger symptom re-
duction of depression and anxiety than those in the con-
trol group. Moreover, we hypothesize that the lesser use
of personnel (i.e. eCoaches) in the unguided condition
will be reflected in a more favorable cost-effectiveness
ratio for this group compared to the guided condition.
This study is part of a large European Horizon 2020 re-
search project (ICare) and will be conducted with similar
study designs, procedures, inclusion and exclusion criteria,
and primary outcome measures among the general popu-
lation in Germany, Switzerland, and Spain. The study
protocol of the other ICare Prevent trials will be pub-
lished elsewhere (Weisel, Zarski, Berger, Krieger, Schaub,
Moser, et al.: Efficacy and cost-effectiveness of guided and
unguided internet-based mobile-supported indicated pre-
vention of depression and anxiety (ICare Prevent): A
multi-country three-armed randomized controlled trial.,
unpublished). Within the large ICare project, several
Internet-based interventions will be used for different
mental health conditions. The overall aim is to increase
access and uptake of such interventions by overcoming
current barriers to implementation and establishing a
comprehensive model of mental health promotion in
Europe. With the goal of improving quality of healthcare,
effectiveness, and acceptance of this kind of intervention,
the ICare project addresses core goals of EU health policy.
Methods/Design
The study is a three-arm, parallel, randomized controlled
superiority trial, with an economic evaluation alongside,
for college students with subclinical symptoms of de-
pression and/or anxiety. An unguided and a guided ver-
sion of ICare Prevent will be compared to CAU in a
Dutch university setting. Next to screening for eligibility,
self-report measures and clinical interviews will be
administered at baseline, mid-intervention, and post inter-
vention, as well as at six-month and 12-month follow-ups.
The ethics committee of the VU medical center has ap-
proved the study (number NL60705.029.17). A populated
SPIRIT checklist and figure have been submitted as
additional files to this publication (see Additional file 1 for
SPIRIT checklist and SPIRIT figure (Additional file 2).
Participants
Students will be recruited and provided with contact de-
tails through e.g. a website (https://icare-online.eu/nl/),
social media (e.g. Facebook), and information material
distributed on campus at Dutch universities. They are
eligible if they: (1) are aged ≥ 16 years; (2) experience at
least mild self-reported symptoms of depression, defined
as a score ≥ 16 on the Center for Epidemiological Studies
Depression scale (CES-D; [41]), and/or anxiety, defined
as a score ≥ 5 on the seven-item version of the General-
ized Anxiety Disorder scale (GAD-7; [42]); (3) do not
meet diagnostic criteria for a mood or anxiety disorder
based on the Mini International Neuropsychiatric Inter-
view (M.I.N.I.; [43]) at screening. Exclusion criteria are:
(1) being on a waitlist for, currently receiving, or having
received psychotherapy over the past six months for any
mental health condition; (2) meeting diagnostic criteria
for a lifetime bipolar disorder (M.I.N.I.) or having re-
ceived a diagnosis of a psychiatric disorder; (3) being at
moderate to severe risk for suicide (M.I.N.I.); (4) being
in remission of a major depressive disorder (MDD) epi-
sode, defined as an MDD diagnosis in the previous six
months and experiencing at least one cardinal symptom
(e.g. persistent and pervasive low mood, loss of interest
or pleasure in usual activities) during the previous three
weeks (M.I.N.I.); (5) self-reported inability to read or
write Dutch; (6) no informed consent; (7) no access to a
computer or the Internet; or (8) participating in similar
studies at time of inclusion.
Study procedures
Upon contact, potential participants will receive an infor-
mation letter and informed consent form by email, the lat-
ter to be signed and returned. In addition, the email
contains a link to the ICare Prevent platform on which par-
ticipants have to register. After the informed consent form
has been returned, the screening questionnaires for all
self-reported inclusion and exclusion criteria will be made
available on the platform. The screening consists of: demo-
graphic questions; the CES-D; and the GAD-7. Next, eli-
gible participants will be asked for their telephone number
in order to conduct the M.I.N.I. interview, the clinician
rated version of the Quick Inventory for Depression Scale
(QIDS-CR; [44]) and the Structured Interview Guide for
the Hamilton Anxiety Rating Scale (SIGH-A; [45]). The in-
terviews will be performed by trained clinical psychology
master students under the supervision of a member of the
research team; 10% will be recorded and rated by a second
rater to assess inter-rater reliability. Consent for the record-
ings will be asked for at the beginning of the call. Disagree-
ment between raters will be solved by discussion or by
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asking an experienced psychotherapist. Eligible participants
will receive a confirmation by email and access to the base-
line self-report questionnaires on the online platform. Once
completed, they will be randomized to one of the two inter-
vention conditions or the control group.
Non-eligible participants will be advised to consult their
general practitioner or a (student) psychologist if they
think they need help for their complaints. Those with
moderate to severe suicide risk will also be advised to con-
tact their general practitioner. In addition, they will be in-
formed about the national suicide helpline (113online;
[46]). The research team will contact those participants
again one week later and ask whether they sought help.
Randomization, treatment allocation, and blinding
The allocation scheme will be derived by computer using
a random number generator at a 1:1:1 ratio. Participants
will be randomized at an individual level by an inde-
pendent institute (University of Münster, Germany) and
randomization will be stratified by type of subclinical
symptoms (depression or anxiety). Due to the nature of
the study it is not possible to blind either participants or
coaches, as they will be notified to which of the three
conditions they have been assigned to. However, raters
who perform the clinical interviews to assess outcomes
will be blinded. In order to ensure that blinding was suc-
cessful, participants will be informed about the import-
ance not to indicate their allocation status at the
beginning of the telephone interviews. Moreover, raters
will be asked to guess the allocation status of each par-
ticipant after the second interview at post intervention.
The results will then be compared to what would have
been expected by chance. The flowchart of the trial is
shown in Fig. 1.
Fig. 1 Study flowchart
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Online intervention platform
The technology platform used to deliver the ICare Prevent
intervention is provided by Minddistrict. This company is
full partner of the ICare project consortium and responsible
for the provision and maintenance of the platform. Its
content management system is used to upload the inter-
ventions, add new participants and eCoaches, as well as
questionnaires. Access to the platform is provided by
means of email and personalized password combination. It
is currently used both in clinical research and in routine
practice to provide guided and unguided self-help interven-
tions for a variety of mental health conditions. The platform
conforms to all required quality standards and operates ac-
cording to the ISO 27000 and NEN 7510 norms. All data
are securely stored on ISO 27000 certified servers and
transmitted using HTTPS with SSL certificates (AES-256
and SHA-1, 2048-bit RSA). Unauthorized access to the
platform is therefore not possible. A data management and
safety plan has been developed as part of the larger ICare
project.
Intervention
ICare Prevent is an Internet-based intervention with
mobile-support by means of an application (app). It uses
both transdiagnostic and individually tailored components
that are based on previously developed Internet-based
modules, all using evidence-based CBT principles [47–
51]. ICare Prevent consists of seven main sessions and
one booster session. Participants are advised to complete
one main session per week. The intervention contains
text, exercises, images, explanatory videos, as well as audio
files and downloadable information. Testimonials are used
to illustrate (homework) exercises. The main sessions fol-
low the same basic structure. First, the content of the
current session is explained, followed by a review of the
homework exercises from the previous session. In accord-
ance with the individually tailored approach of the inter-
vention, participants can choose content depending on
their predominant complaints, i.e. depression or anxiety.
For example, in the fifth session, participants can either
practice problem-solving or exposure techniques. The
content per session is summarized in Table 1. Throughout
sessions 2–7, participants can choose to complete one of
eight choice modules following the main intervention
content. In accordance with the transdiagnostic approach
of the intervention, these modules aim at increasing resili-
ence and tackle problems common to both depression
and anxiety. In addition, five diaries with different content,
such as positive activities and sleep, are accessible through
the online platform and the app. An overview of all choice
modules and diaries is given in Table 2.
The intervention can be used on (laptop) computers, mo-
bile phones, and tablets. The mobile app can be used op-
tionally. It provides access to the diaries and allows
participants to activate push notifications. These short mes-
sages contain small exercises, such as short relaxation tech-
niques, as well as motivational texts. The intervention uses
a responsive web design in order to tailor content to partic-
ipants’ needs, based on the choices they make. An optional
read-aloud function is included. The expected time to
complete each session is approximately 60 min. The two
intervention conditions only differ in the support partici-
pants receive. In the guided condition, trained eCoaches
(clinical psychology master students) spend approximately
20 min, but no more than 30 min per session on sending
individual manualized feedback on the exercises through
the intervention platform. In addition, they will send
Table 1 Overview of topics covered by the intervention per
session
Session Topic
1 Introduction, technical aspects, goal-setting, and behavioral
activation in the context of basic psychological needs and
important personal values
2 Identifying problems and tackling them through behavioral
activation
3 Psychoeducation on depression and anxiety
4 Cognitive restructuring and challenging negative thoughts
5 Identifying the most prominent complaints and accordingly
follow either:
a) problem-solving strategies for more prominent depressive
complaintsb) exposure strategies for more prominent anxiety
complaints
6 Deepening the training on the route chosen in session 5
7 Making a plan for the future
8 Booster session (four weeks after session 7)
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reminders for module completion in order to increase ad-
herence. The eCoaches will be supervised by the members
of the research team. Participants in the unguided condi-
tion receive only automatic motivational messages that aim
to increase adherence by positively reinforcing participants
for completing intervention modules and reminding them
in case of a delay in completion.
Care as usual (CAU)
Participants in all three conditions may use CAU services.
We monitor healthcare services used, as well as other
means to alleviate symptoms (e.g. as talking with relatives
and friends), by means of a self-report questionnaire, the
Client Service Receipt Inventory (CSRI; [52]). In the
Netherlands, CAU for subclinical symptoms of depression
and/or anxiety can include visits to the general practitioner,
making use of support staff trained in the provision of help
for mild psychological symptoms, or (student) psychologists
according to Dutch guidelines [53, 54]. Alternatives include
homeopaths, alternative medicine providers, or self-
medication. Participants in the control group will receive
access to ICare Prevent one year after trial inclusion.
Measures
Following screening and baseline (all groups), assess-
ment points for the intervention groups include five
weeks after randomization or directly after session 5
(whichever happens first) and eight weeks after
randomization or post intervention (whichever hap-
pens first). Assessment points for the control group
include five and eight weeks after randomization.
Follow-up measures for all three groups consist of
six and 12 months after randomization. Assessments
include self-report questionnaires on the intervention
platform and diagnostic interviews administered over
the telephone. An overview of all measures taken by
assessment point is given in Table 3.
Screening
Depression
The CES-D [41] will be used as a screening instru-
ment. It has been shown to be reliable and valid in
studies across different populations, including stu-
dents [55, 56].
Anxiety
The GAD-7 [42] will be used both as screening as well
as outcome measure. It has been tested in students as
well as different age groups and showed excellent reli-
ability and validity [57, 58].
Demographic data, self-reported mental disorder diagnosis,
and experience with psychotherapy
In addition to demographic data, such as age, partici-
pants indicate if they have ever received a diagnosis of
Table 3 Overview of instruments with associated assessment
points
Measure (instrument) Assessment point
T0 T1 T2 T3 T4 T5
Screening
Depression (CES-D) X
Anxiety (GAD-7) X X X X X
Demographic data X
Mental disorder diagnosis self-reported X
Experience with psychotherapy X
Clinical diagnosis (M.I.N.I.) X X X
Primary outcomes
Depression (QIDS) X X X X
Anxiety (SIGH-A) X X X X
Secondary outcomes
Depression (PHQ-9) X X X X X
Anxiety (GAD-7) X X X X X
Clinical diagnosis (M.I.N.I.) X X X
Academic performance (PSS, ECTS) X X X X X
Cost-effectiveness
Costs (CSRI) X X X
Other outcomes
Alcohol use (AUDIT-C) X X X X X
Alliance (WAI-SR)a X
Behavioral activation (BADS-SF) X X X X
Reasons for dropouta X
Expectations (CEQ) X
Incongruence (INKK) X X X X
Motivation (TEQ) X X X
Negative effects of treatment (INEP)a X
Personality (BFI-10) X
Potential risk factorsb X
Program evaluation (CSQ-8)a X X
Quality of life (AQoL, EQ-5D-8 L) X X X X
Resilience (CD-RISC) X X X X X
Sleep quality (PSQI) X X X X
Supporta X
Wellbeing (WHO-5) X X X X
Worry (PSWQ-3) X X X X
aOnly in intervention groups
bOptional
T0 screening, T1 baseline, T2 after completion of session 5 or 5 weeks after
randomization, T3 post intervention, T4 6-month follow-up, T5
12-month follow-up
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any, and, if so, which, mental health disorder and
whether they have ever utilized psychological treatment
for any mental health condition.
Diagnostic interview
The M.I.N.I. [43] will be administered by telephone to es-
tablish DSM-V diagnoses of mood and anxiety disorders,
bipolar disorder, psychosis, and the risk for suicide during
screening. The reliability and validity of the M.I.N.I. has
been established among several populations [59, 60].
Primary outcome
The primary outcome is change in disorder-specific symp-
tom severity from baseline to post intervention. For de-
pression, this will be assessed using the QIDS-CR [44].
This interview has been used in different settings and has
good psychometric properties [44, 61]. The SIGH-A [45]
will be used for the assessment of anxiety. Its reliability
and validity has been found to be good [45].
Secondary outcomes
Secondary outcomes include self-reported reduction in
depressive and anxiety symptoms from baseline to post
intervention. In addition to screening, the GAD-7 will be
used to measure anxiety symptoms throughout the trial.
The nine-item Patient Health Questionnaire (PHQ-9;
[62]) will be used to assess depressive symptoms. Research
on the PHQ-9 has generally shown good psychometric
properties among all age groups [62–64]. Moreover, the
time to onset of a mood or anxiety disorder within the 12-
month follow-up period will be assessed by the M.I.N.I.
Finally, academic performance will be measured by the
Presenteeism Scale for Students (PSS; [65]). It is a valid
and reliable measure that will be used to assess presentee-
ism in the student population [65]. In addition, students
will be asked to provide the number of points they ac-
quired on the European Credit Transfer System (ECTS)
during the semester.
Costs
The CSRI [52] will be used to track societal costs. It has
been adapted to the specifics of the Dutch college stu-
dent context, measuring costs associated with healthcare
use. In addition, it assesses absenteeism and presentee-
ism in college as well as in student jobs. For the latter,
the Dutch minimum wage will be taken as an estimate
of students’ income.
Other outcomes, moderators, and mediators
Alcohol use
Alcohol use will be monitored by the three consumption
questions of the brief Alcohol Use Disorders Identifica-
tion Test (AUDIT-C; [66]). The AUDIT-C has shown
good psychometric properties in college students [67].
Moreover, it has been used both as a screening as well
as outcome instrument [68, 69].
Alliance (only intervention arms)
An adapted version of the self-rated Working Alliance
Inventory (WAI-SR; [70]) will be administered to the
active intervention groups. Questions relating to the
bond with the coach will be asked only in the guided
condition. The original form of the WAI-SR has
shown good psychometric properties [70, 71].
Behavioral activation
The short form of the Behavioral Activation for Depres-
sion Scale (BADS-SF; [72, 73]) assesses activation and
engagement in pleasant activities. The reliability and val-
idity of the questionnaire has been established in a col-
lege student sample [74].
Dropout
Participants will be asked whether and why they have
prematurely stopped using the intervention.
Expectations (only intervention arms)
The Credibility/Expectancy Questionnaire (CEQ; [75])
will be used to assess participants’ expectations of the
intervention. Its reliability and validity has been estab-
lished and the questionnaire has been used in college
student samples [75, 76].
Incongruence
ICare Prevent aims at reducing the gap between motiv-
ational goals and their actual execution. The short ver-
sion of the incongruence questionnaire (INKK; [77])
measures the extent to which this is achieved.
Motivation
The Treatment Entry Questionnaire (TEQ; [78]) will be
used to assess motivation to participate in the study. Re-
search has indicated good psychometric properties for
the TEQ in a Dutch psychiatric sample [79].
Negative effects of the intervention (only in intervention
arms)
The Inventory for the Assessment of Negative Effects of
Psychotherapy (INEP; [80]) measures possible negative
aspects of using the intervention.
Personality
The ten-item Big Five Inventory (BFI-10; [81, 82]) will
be used as a brief measure of personality. Its psychomet-
ric properties have been established in a college student
sample [82].
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Potential risk factors
Participants can choose if they want to answer a battery
of potential risk factors for mental wellbeing that have
been suggested by the literature, such as smoking, body
image, and childhood abuse.
Program evaluation (only in intervention arms)
The eight-item Client Satisfaction Questionnaire has
been adapted to this online context (CSQ-8; [83, 84]). It
assesses participants’ satisfaction with the intervention.
The psychometric properties of the Dutch version have
been found to be good [85].
Quality of life
In addition to the Assessment of Quality of Life ques-
tionnaire (AQoL-8D; [86, 87]), the EuroQol (EQ-5D-5 L;
[88]) will be administered. This enables the calculation
of quality-adjusted life-years (QALYs) and converting
health states into utility scores using the Dutch EQ-5D-
5 L tariff [89]. Both instruments have established psy-
chometric properties [86, 90].
Resilience
The ten-item version of the Connor-Davidson Resilience
Scale (CD-RISC; [91]) measures how good individuals
can work under pressure or how strong they think they
are. The CD-RISC has been used in college samples and
its reliability and validity has been well established in dif-
ferent populations [92–94].
Sleep quality
One item on sleep quality from the Pittsburgh Sleep
Quality Index (PSQI; [95]) will be administered. The
PSQI has been used extensively in college samples
[96, 97].
Support (only in guided intervention arm)
Seven items have been developed by the research team
to assess the relationship between participants and their
eCoach (e.g. “I think my eCoach appreciates me less if I
use ICare Prevent less often than expected”), as well as
how they would rate the eCoach’s competency (e.g. “I
think my eCoach is very competent”).
Wellbeing
Wellbeing will be measured by the five-item version of
the World Health Organization Ten Well-Being Index
(WHO-5; [98]). Good psychometric properties of this in-
strument have been established in a college and Dutch
population [99, 100].
Worry
The ultra-brief version of the Penn State Worry Ques-
tionnaire (PSWQ-3; [101]) has good psychometric
properties and will be administered to examine excessive
worrying [101, 102].
Sample size calculation
The primary endpoint is change in disorder specific
symptom severity from baseline to post intervention.
Based on the evidence from a meta-analysis by Cuijpers
et al. [103] on the effectiveness of psychotherapies for
subclinical symptoms of depression, as well as a random-
ized controlled trial on the effectiveness of an Internet-
based intervention for subclinical depression ([24–26],
the expected effect size is d = 0.35. Due to a lack of infor-
mation on effect sizes for subclinical symptoms of anx-
iety, d = 0.25 is used as a conservative estimation for both
conditions. A study comparing the effectiveness of
Internet-based psychotherapy with different levels of sup-
port found effect sizes in a similar range [39]. The sample
size calculation is based on a repeated measure ANOVA
and follows the recommendations given in Muller [104]
and Muller et al. [105]. Thus, based on a global signifi-
cance level α = 0.05 and power β = 0.95, 252 participants
(84 per study arm) will be needed for an effect of 0.25 to
be significant.
Statistical analysis
All analyses for the primary and secondary outcomes
will be based on multilevel mixed model regression ana-
lyses for continuous outcomes in order to assess change
over time. Time will be used as a predictor variable and
baseline measures will be included as covariates. Linear
models will be used for normally distributed data and
negative binomial models for left-skewed data. All ana-
lyses will be performed on an intention-to-treat (ITT)
sample. Per-protocol analyses including only participants
who conformed to their group allocation will be per-
formed in addition. Missing data will be handled using
either multiple regression imputation techniques if ap-
propriate or full information maximum likelihood esti-
mation [106]. The secondary outcome, time to mental
health disorder onset during 12 months follow-up in all
conditions, measured by the M.I.N.I., will also be com-
pared using survival curve analysis. The curves will be
compared using cox proportional hazard regression ana-
lysis using baseline symptom severity as a covariate.
Hazard ratios will be calculated as measure of the effect
size of group differences. Within secondary analyses, in-
teractions with predictors will be added to the model in
order to identify risk and protective factors.
Cost-effectiveness
Cost-effectiveness will be assessed from a societal perspec-
tive for both disorder-free days and QALYs. The analysis
will be performed according to the ITT principle. Multiple
imputation according to the MICE algorithm developed
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by Van Buuren et al. [107] will be used to impute missing
cost and effect data. Incremental cost-effectiveness ratios
(ICERs) will be calculated by dividing the pairwise differ-
ences in the mean societal costs between the groups by
the pairwise differences in mean effects between the
groups. Bivariate regression models will be used to esti-
mate cost and effect differences while adjusting for con-
founding if necessary. Statistical uncertainty will be
estimated using bias-corrected accelerated bootstrapping
with 5000 replications. Uncertainty surrounding the
ICERs will be presented in cost-effectiveness planes and
acceptability curves [108].
Discussion
The high prevalence and burden of depression and anx-
iety, both on an individual and societal level, warrant ef-
fective and low-threshold prevention strategies. Students
are considered an at-risk group for developing these con-
ditions due to their age of onset and the challenges that
this population faces [6]. So far, research on the effective-
ness of Internet-based prevention in college students is
largely limited to the field of eating disorders and sub-
stance use [109, 110]. However, scientific evidence on the
value of, in particular, transdiagnostic individually tailored
interventions for the indicated prevention of depression
and anxiety among college students is scarce.
Based on these considerations, we have developed the
ICare Prevent intervention. Originally conceived for the
indicated prevention in the general population in
Germany, we have adapted it to a Dutch college student
context. To do that, we have started with a literal trans-
lation from German into Dutch. In addition, focus
groups have been conducted with students to map out
core features that are attractive to them. As a result, the
intervention has been shortened considerably while leav-
ing the psychotherapeutic components intact. This was
assured by the supervision of a licensed psychotherapist.
Moreover, problem descriptions and the testimonials
have been changed to represent the diverse student
population and their experiences related to study stress,
balancing work and studies, as well as dealing with fam-
ily members, partners, and friends.
Strengths and limitations
To our knowledge, this is the first trial that investigates the
(cost-)effectiveness of a transdiagnostic individually tailored
Internet-based intervention for the prevention of depres-
sion and anxiety in a college student population. Data on
both symptom reduction as well as the time to onset of a
mood or anxiety disorder will be measured. Although some
research suggests that Internet-based interventions have
the potential to be cost-effective compared to no treatment,
no data are available for preventive transdiagnostic indi-
vidually tailored Internet-based interventions for college
students. Specifically, the added (economic) value of sup-
port by means of an eCoach needs to be closely monitored
in the context of this low-intensity intervention.
Some possible limitations of the present trial should
be noted. First, the sample size of this trial conducted
among Dutch college students is insufficient for dir-
ectly comparing the guided and unguided treatment
arm as well as analyzing the time to a mental health
disorder onset. Similarly, analyses of moderators and
mediators will be underpowered and may therefore
provide only limited insights. To counter this issue,
data from all participating trials in the ICare project
will be pooled in order to achieve enough statistical
power. Second, an evaluation of societal costs might
be difficult due to the fact that most students are sel-
dom in full-time employment. The detrimental effect
of depression and anxiety on absenteeism and pres-
enteeism in the context of employment is therefore
difficult to quantify. In order to increase the validity
of the results, we have adapted the cost-effectiveness
questionnaire (CSRI; [52]) to fit the specifics of a stu-
dent population by focusing on absenteeism and pres-
enteeism in student jobs, as well as in lectures.
Finally, previous research has shown that adherence
to Internet interventions is a point of concern, espe-
cially in unguided formats [111, 112]. A series of
automatic motivational messages and reminders will
be used in order to increase adherence in the un-
guided study arm and we will closely observe factors
related to dropout. This will be beneficial in designing
future interventions and improving uptake of inter-
vention content.
Trial status
Recruitment started in July 2017. Follow-up assessments
for the last participant are expected to be completed by
31 August 2019.
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